CORC

在结果中检索

CORC

浏览/检索结果: 共20条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Third-generation EGFR inhibitor HS-10296 in combination with famitinib, a multi-targeted tyrosine kinase inhibitor, exerts synergistic antitumor effects through enhanced inhibition of downstream signaling in EGFR-mutant non-small cell lung cancer cells 期刊论文
THORACIC CANCER, 2021, 页码: 9
作者:  Zhang, Mi;  Quan, Haitian;  Fu, Li;  Li, Yun;  Fu, Haoyu
收藏  |  浏览/下载：18/0  |  提交时间：2021/05/24
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial 期刊论文
CHINESE JOURNAL OF CANCER, 2017, 卷号: 36
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Ke-Ming;  Wu, Gang;  Shi, Chun-Mei
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‑blinded, placebo‑controlled, phase II clinical trial 期刊论文
2017, 卷号: 36, 期号: 12, 页码: 677-685
作者:  Xu Ruihua;  Shen Lin;  Wang Keming;  Wu Gang;  Shi Chunmei
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial 期刊论文
2017, 卷号: 36, 期号: 1, 页码: 97
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Ke-Ming;  Wu, Gang;  Shi, Chun-Mei
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Metabolic research of domestically developed small molecule tyrosine kinase inhibitors 期刊论文
Acta Pharmaceutica Sinica, 2016, 卷号: 51, 期号: 2, 页码: 248-256
作者:  Jiang Jinfang;  Chen Xiaoyan;  Zhong Dafang
收藏  |  浏览/下载：25/0  |  提交时间：2019/01/08
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 会议论文
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/19
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-01-20
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04
A randomized, double-blind, parallel-group, placebo-controlled, multicenter, phase II clinical study of famitinib in the treatment of advanced metastatic colorectal cancer 期刊论文
2015, 卷号: 33, 期号: 3
作者:  Xu, Rui-Hua;  Shen, Lin;  Wang, Keming;  Wu, Gang;  Shi, Chunmei
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
HYPOTHYROIDISM AS A POTENTIAL BIOMARKER OF EFFICACY OF FAMITINIB, A NOVEL VEGFR2 INHIBITOR IN METASTATIC BREAST CANCER 会议论文
作者:  Cao, J.;  Zhang, J.;  Wang, Z. H.;  Wang, B. Y.;  Lv, F. F.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19
Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR-2 inhibitor in metastatic breast cancer 期刊论文
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 卷号: 74, 期号: 2
作者:  Cao, Jun;  Zhang, Jian;  Wang, Zhonghua;  Wang, Biyun;  Lv, Fangfang
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace